Meridian Introduces Critical Raw Materials for Nipah Virus Diagnosis, a Key Emerging Disease on the WHO’s Priority List
CINCINNATI, May 30, 2018 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the availability of critical antigens and antibodies for Nipah virus immunological assay development in response to the World Health Organization’s (WHO) list of eight priority diseases that could cause severe outbreaks or have epidemic potential. Last week, at least 13 people died […]